The CML THERAPY brand, founded in 2012 (United States), from 496 sister brands and 17477 competing brands. The CML THERAPY brand is owned by BRISTOL-MYERS SQUIBB COMPANY, a company listed in New York. CML THERAPY belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY
(CML THERAPY)
over 5 years*
USD 62.45